HEMAB THERAPEUTICS HOLDINGS (COAG) Institutional Ownership Changes & 13F Activity
HEMAB THERAPEUTICS HOLDINGS (COAG). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ra Capital Management, L.P., Novo Holdings A/S, Deep Track Capital, Lp, Avoro Capital Advisors Llc, and Bain Capital Life Sciences Investors, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Buy | +18,720 | — | 18,720 | $687.59K | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Buy | +523,450 | — | 523,450 | $19.23M | Q2 2026 | Sep 02, 2026 |
| Ra Capital Management, L.P. | Buy | +7,808,627 | — | 7,808,627 | $286.81M | Q2 2026 | Aug 14, 2026 |
| Novo Holdings A/S | Buy | +4,180,550 | — | 4,180,550 | $153.55M | Q2 2026 | Aug 14, 2026 |
| Deep Track Capital, Lp | Buy | +3,602,093 | — | 3,602,093 | $132.30M | Q2 2026 | Aug 14, 2026 |
| Avoro Capital Advisors Llc | Buy | +1,925,150 | — | 1,925,150 | $70.71M | Q2 2026 | Aug 14, 2026 |
| Bain Capital Life Sciences Investors, Llc | Buy | +1,650,000 | — | 1,650,000 | $60.60M | Q2 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Buy | +746,040 | — | 746,040 | $27.40M | Q2 2026 | Aug 14, 2026 |
| Driehaus Capital Management Llc | Buy | +715,791 | — | 715,791 | $26.29M | Q2 2026 | Aug 14, 2026 |
| Rock Springs Capital Management Lp | Buy | +575,432 | — | 575,432 | $21.14M | Q2 2026 | Aug 14, 2026 |
| Bellevue Group Ag | Buy | +550,000 | — | 550,000 | $20.20M | Q2 2026 | Aug 14, 2026 |
| Deerfield Management Company, L.P. | Buy | +275,000 | — | 275,000 | $10.10M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +218,287 | — | 218,287 | $8.02M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Buy | +160,000 | — | 160,000 | $5.88M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +150,040 | — | 150,040 | $5.51M | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Buy | +115,394 | — | 115,394 | $4.24M | Q2 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Buy | +108,236 | — | 108,236 | $3.98M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +81,928 | — | 81,928 | $3.01M | Q2 2026 | Aug 14, 2026 |
| Burkehill Global Management, Lp | Buy | +75,000 | — | 75,000 | $2.75M | Q2 2026 | Aug 14, 2026 |
| Opaleye Management Inc. | Buy | +47,652 | — | 47,652 | $1.75M | Q2 2026 | Aug 14, 2026 |
| Parkman Healthcare Partners Llc | Buy | +45,000 | — | 45,000 | $1.65M | Q2 2026 | Aug 14, 2026 |
| Ghisallo Capital Management Llc | Buy | +40,000 | — | 40,000 | $1.47M | Q2 2026 | Aug 14, 2026 |
| Seven Grand Managers, Llc | Buy | +30,000 | — | 30,000 | $1.10M | Q2 2026 | Aug 14, 2026 |
| Soros Fund Management Llc | Buy | +25,000 | — | 25,000 | $918.25K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +17,389 | — | 17,389 | $638.70K | Q2 2026 | Aug 14, 2026 |
| Hudson Bay Capital Management Lp | Buy | +12,202 | — | 12,202 | $448.18K | Q2 2026 | Aug 14, 2026 |
| Schonfeld Strategic Advisors Llc | Buy | +10,813 | — | 10,813 | $397.16K | Q2 2026 | Aug 14, 2026 |
| Weiss Asset Management Lp | Buy | +10,000 | — | 10,000 | $367.30K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +6,252 | — | 6,252 | $229.64K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +5,680 | — | 5,680 | $208.63K | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about COAG activity
Which institutional owners are buying COAG?
Institutional owners buying COAG include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in COAG activity?
"Buy" means an investor increased their reported position in COAG compared to the prior reporting period. This reflects growing exposure to HEMAB THERAPEUTICS HOLDINGS (COAG) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in COAG increasing?
Institutional interest in COAG can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.